Brazil · Delayed Price · Currency is BRL Fresenius Medical Care AG Statistics
Total Valuation
BVMF:FMSC34 has a market cap or net worth of BRL 66.08 billion. The enterprise value is 127.46 billion.
| Market Cap | 66.08B |
| Enterprise Value | 127.46B |
Important Dates
The next confirmed earnings date is Thursday, March 12, 2026.
| Earnings Date | Mar 12, 2026 |
| Ex-Dividend Date | May 22, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.76% |
| Shares Change (QoQ) | -2.12% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 45.92% |
| Float | 189.92M |
Valuation Ratios
The trailing PE ratio is 10.44 and the forward PE ratio is 9.62.
| PE Ratio | 10.44 |
| Forward PE | 9.62 |
| PS Ratio | 0.52 |
| PB Ratio | 0.72 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.79 |
| P/OCF Ratio | 3.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.04, with an EV/FCF ratio of 11.16.
| EV / Earnings | 20.14 |
| EV / Sales | 1.06 |
| EV / EBITDA | 6.04 |
| EV / EBIT | 10.16 |
| EV / FCF | 11.16 |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.76.
| Current Ratio | 1.26 |
| Quick Ratio | 0.85 |
| Debt / Equity | 0.76 |
| Debt / EBITDA | 3.31 |
| Debt / FCF | 6.12 |
| Interest Coverage | 4.86 |
Financial Efficiency
Return on equity (ROE) is 7.93% and return on invested capital (ROIC) is 6.34%.
| Return on Equity (ROE) | 7.93% |
| Return on Assets (ROA) | 3.62% |
| Return on Invested Capital (ROIC) | 6.34% |
| Return on Capital Employed (ROCE) | 7.55% |
| Weighted Average Cost of Capital (WACC) | 6.01% |
| Revenue Per Employee | 1.16M |
| Profits Per Employee | 57,678 |
| Employee Count | 109,698 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 6.94 |
Taxes
In the past 12 months, BVMF:FMSC34 has paid 2.08 billion in taxes.
| Income Tax | 2.08B |
| Effective Tax Rate | 21.22% |
Stock Price Statistics
The stock price has decreased by -11.06% in the last 52 weeks. The beta is 0.94, so BVMF:FMSC34's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | -11.06% |
| 50-Day Moving Average | 119.07 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 46.25 |
| Average Volume (20 Days) | 72 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BVMF:FMSC34 had revenue of BRL 126.93 billion and earned 6.33 billion in profits. Earnings per share was 21.73.
| Revenue | 126.93B |
| Gross Profit | 32.52B |
| Operating Income | 12.09B |
| Pretax Income | 9.78B |
| Net Income | 6.33B |
| EBITDA | 16.96B |
| EBIT | 12.09B |
| Earnings Per Share (EPS) | 21.73 |
Balance Sheet
The company has 11.25 billion in cash and 69.90 billion in debt, with a net cash position of -58.65 billion.
| Cash & Cash Equivalents | 11.25B |
| Total Debt | 69.90B |
| Net Cash | -58.65B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 92.37B |
| Book Value Per Share | 308.20 |
| Working Capital | 10.69B |
Cash Flow
In the last 12 months, operating cash flow was 17.34 billion and capital expenditures -5.92 billion, giving a free cash flow of 11.42 billion.
| Operating Cash Flow | 17.34B |
| Capital Expenditures | -5.92B |
| Free Cash Flow | 11.42B |
| FCF Per Share | n/a |
Margins
Gross margin is 25.62%, with operating and profit margins of 9.53% and 4.98%.
| Gross Margin | 25.62% |
| Operating Margin | 9.53% |
| Pretax Margin | 7.70% |
| Profit Margin | 4.98% |
| EBITDA Margin | 13.36% |
| EBIT Margin | 9.53% |
| FCF Margin | 9.00% |
Dividends & Yields
This stock pays an annual dividend of 3.07, which amounts to a dividend yield of 2.52%.
| Dividend Per Share | 3.07 |
| Dividend Yield | 2.52% |
| Dividend Growth (YoY) | 36.08% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 43.19% |
| Buyback Yield | 0.76% |
| Shareholder Yield | 3.28% |
| Earnings Yield | 9.58% |
| FCF Yield | 17.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BVMF:FMSC34 has an Altman Z-Score of 1.92 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.92 |
| Piotroski F-Score | 7 |